Cerevel Therapeutics Holdings, Inc.
CERE · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $991 | $137 | $193 | $384 |
| Short-Term Investments | $0 | $756 | $373 | $0 |
| Receivables | $5 | $0 | $1 | $0 |
| Inventory | $0 | -$2 | -$1 | $0 |
| Other Curr. Assets | $11 | $14 | $12 | $7 |
| Total Curr. Assets | $1,007 | $906 | $578 | $391 |
| Property Plant & Equip (Net) | $46 | $49 | $52 | $49 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $187 | $58 | $52 | $4 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $3 | $5 | $7 | $2 |
| Total NC Assets | $236 | $112 | $111 | $55 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,243 | $1,018 | $689 | $445 |
| Liabilities | – | – | – | – |
| Payables | $12 | $10 | $11 | $5 |
| Short-Term Debt | $3 | $3 | $2 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $28 | $22 |
| Other Curr. Liab. | $77 | $60 | $29 | $23 |
| Total Curr. Liab. | $92 | $73 | $43 | $30 |
| LT Debt | $365 | $367 | $34 | $31 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $112 | $57 | $34 | $0 |
| Total NC Liab. | $477 | $424 | $68 | $31 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $570 | $497 | $110 | $61 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,401 | -$968 | -$616 | -$391 |
| AOCI | $2 | $3 | -$1 | $0 |
| Other Equity | $2,073 | $1,486 | $1,196 | $775 |
| Total Equity | $674 | $521 | $579 | $385 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,243 | $1,018 | $689 | $445 |
| Net Debt | -$622 | $233 | -$156 | -$351 |